Since multiple genes of the PI3K/Akt/mTOR signaling pathway are frequently altered in human cancers, dysregulation through mutation or amplification of genes involved in the PI3K pathway, loss of the tumor suppressor PTEN or over-activation of RTK leads to tumor progression and metastasis. Here, PTEN is linked to neoplasm.